Annual Report 2023 | Page 5

EVAN WU , MD , PHD
Assistant Professor ( Assistant Researcher ), Translational and Clinical Research Program Thoracic Medical Oncology , Hawai ‘ i Pacific Health – Pali Momi Cancer Center Dr . Wu earned his PhD in Biostatistics from Johns Hopkins University , his MD from the University of Miami , and his medical oncology fellowship training from the Johns Hopkins School of Medicine . His research focuses on thoracic cancers , including lung cancer and mesothelioma . As AstraZeneca ’ s medical director of early oncology , he led the development of targeted therapies for lung cancer and several clinical trials on lung cancer , mesothelioma , and cellular therapy for HPV-associated cancers . Dr . Wu strives to identify new therapies to improve the lives of patients with thoracic cancers .
XUEMEI XIE , PHD
Assistant Professor ( Assistant Researcher ), Cancer Biology Program Dr . Xie received her PhD in Recombinant Antibody Engineering Technology from the School of Environmental Sciences at the University of Guelph in Canada . Her research focuses on translational breast cancer research . She is currently investigating the contribution of MAPK / JNK signaling to the aggressiveness of triple-negative breast cancer ( TNBC ), defining the impact of an immunosuppressive tumor microenvironment on TNBC aggressiveness , and responses to chemoimmunotherapy and developing novel targeted combination chemoimmunotherapy for TNBC . Her mission is to establish targeted therapies that will transform the lives of patients suffering from this devastating disease .
HIDEKO YAMAUCHI , MD , FACS
Professor ( Researcher ), Translational and Clinical Research Program Breast Surgical Oncology , The Queen ’ s Medical Center Dr . Yamauchi received her MD from the Juntendo University School of Medicine in Japan . Her breast cancer research began at the Dana-Farber Cancer Institute , Harvard University , and continued at the Lombardi Cancer Center , Georgetown University . She served as director of the Breast Center at St . Luke ’ s International Hospital in Japan . Her research interests include breast cancer , survivorship , and genetics . Dr . Yamauchi is eager to collaborate with other researchers to improve breast cancer prognosis , provide better survivorship care , and prevent breast cancer for people in Hawai ‘ i .
TERUO YAMAUCHI , MD , MSMS
Professor ( Researcher ), Translational and Clinical Research Program Breast and Gastrointestinal Medical Oncology , The Queen ’ s Medical Center Dr . Yamauchi completed his MD at Kagoshima University in Japan , an internal medicine residency at the UH John A . Burns School of Medicine , and a fellowship in hematology and medical oncology and a Master of Science in Medical Sciences from the Moffitt Cancer Center . He served as the chief of medical oncology at St . Luke ’ s International Hospital in Japan . Dr . Yamauchi is passionate about breast cancer research and will work with other UH Cancer Center experts to develop personalized treatment plans and find better solutions .
3